FOFinbarr O'Sullivan

Finbarr O'Sullivan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Finbarr O'Sullivan has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mapping18F-FDG Kinetics Together with Patient-Specific Bootstrap Assessment of Uncertainties: An Illustration with Data from a PET/CT Scanner with a Long Axial Field of View

    by Qi Wu, Fengyun Gu, Liam D. O’sUilleabhain, Hasan Sari, Song Xue, Kuangyu Shi, Axel Rominger, Finbarr O’sUllivan

    The purpose of this study was to examine a nonparametric approach to mapping kinetic parameters and their uncertainties with data from the emerging generation of dynamic whole-body PET/CT scanners. Methods: Dynamic PET 18F-FDG data from a set of 24 cancer patients studied on a long-axial-field-of-view PET/CT scanner were considered. Kinetics were mapped using a nonparametric residue mapping (NPRM) technique. Uncertainties were evaluated using an image-based bootstrapping methodology. Kinetics and bootstrap-derived uncertainties are reported for voxels, maximum-intensity projections, and volumes of interest (VOIs) corresponding to several key organs and lesions. Comparisons between NPRM and standard 2-compartment (2C) modeling of VOI kinetics are carefully examined. Results: NPRM-generated kinetic maps were of good quality and well aligned with vascular and metabolic 18F-FDG patterns, reasonable for the range of VOIs considered. On a single 3.2-GHz processor, the specification of the bootstrapping model took 140 min; individual bootstrap replicates required 80 min each. VOI time-course data were much more accurately represented, particularly in the early time course, by NPRM than by 2C modeling constructs, and improvements in fit were statistically highly significant. Although 18F-FDG flux values evaluated by NPRM and 2C modeling were generally similar, significant deviations between vascular blood and distribution volume estimates were found. The bootstrap enables the assessment of quite complex summaries of mapped kinetics. This is illustrated with maximum-intensity maps of kinetics and their uncertainties. Conclusion: NPRM kinetics combined with image-domain bootstrapping is practical with large whole-body dynamic 18F-FDG datasets. The information provided by bootstrapping could support more sophisticated uses of PET biomarkers used in clinical decision-making for the individual patient. Visual Abstract


  • Open Access

    PET AIF estimation when available ROI data is impacted by dispersive and/or background effects

    by Finbarr O’SUllivan

    Objective. Blood pool region of interest (ROI) data extracted from the field of view of a PET scanner can be impacted by both dispersive and background effects. This circumstance compromises the ability to correctly extract the arterial input function (AIF) signal. The paper explores a novel approach to addressing this difficulty. Approach. The method involves representing the AIF in terms of the whole-body impulse response (IR) to the injection profile. Analysis of a collection/population of directly sampled arterial data sets allows the statistical behaviour of the tracer’s impulse response to be evaluated. It is proposed that this information be used to develop a penalty term for construction of a data-adaptive method of regularisation estimator of the AIF when dispersive and/or background effects maybe impacting the blood pool ROI data. Main results. Computational efficiency of the approach derives from the linearity of the impulse response representation of the AIF and the ability to substantially rely on quadratic programming techniques for numerical implementation. Data from eight different tracers, used in PET cancer imaging studies, are considered. Sample image-based AIF extractions for brain studies with: 18 F-labeled fluoro-deoxyglucose and fluoro-thymidine (FLT), 11 C-labeled carbon dioxide (CO2) and 15 O-labeled water (H2O) are presented. Results are compared to the true AIF based on direct arterial sampling. Formal numerical simulations are used to evaluate the performance of the AIF extraction method when the ROI data has varying amounts of contamination, in comparison to a direct approach that ignores such effects. It is found that even with quite small amounts of contamination, the mean squared error of the regularised AIF is significantly better than the error associated with direct use of the ROI data. Significance. The proposed IR-based AIF extraction scheme offers a practical methodological approach for situations where the available image ROI data may be contaminated by background and/or dispersion effects.

  • Open Access

    A Generalized Linear modeling approach to bootstrapping multi-frame PET image data

    by Finbarr O’SUllivan, Fengyun Gu, Qi Wu, Liam D O’SUilleabhain


  • Open Access

    Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687

    by Mark Muzi, Finbarr O’sullivan, Timothy G. Perk, John P. Muzi, David A. Mankoff, Robert Jeraj, Fenghai Duan, Evan Y. Yu

    ACRIN 6687, a multi-center clinical trial evaluating differential response of bone metastases to dasatinib in men with metastatic castration-resistant prostate cancer (mCRPC), used [18F]-fluoride (NaF) PET imaging. We extend previous ACRIN 6687 dynamic imaging results by examining NaF whole-body (WB) static SUV PET scans acquired after dynamic scanning. Eighteen patients underwent WB NaF imaging prior to and 12 weeks into dasatinib treatment. Regional VOI analysis of the most NaF avid bone metastases and an automated whole-body method using Quantitative Total Bone Imaging software (QTBI; AIQ Solutions, Inc., Madison, WI, USA) were used. We assessed differences in tumor and normal bone, between pre- and on-treatment dasatinib, and evaluated parameters in association with PFS and OS. Significant decrease in average SUVmax and average SUVpeak occurred in response to dasatinib. Univariate and multivariate analysis showed NaF uptake had significant association with PFS. Pharmacodynamic changes with dasatinib in tumor bone can be identified by WB NaF PET in men with mCRPC. WB PET has the benefit of examining the entire body and is less complicated than single FOV dynamic imaging.


  • Spatial Auto-Regressive Analysis of Correlation in 3-D PET With Application to Model-Based Simulation of Data

    by Jian Huang, Tian Mou, Kevin O'REgan, Finbarr O'SUllivan

    When a scanner is installed and begins to be used operationally, its actual performance may deviate somewhat from the predictions made at the design stage. Thus it is recommended that routine quality assurance (QA) measurements be used to provide an operational understanding of scanning properties. While QA data are primarily used to evaluate sensitivity and bias patterns, there is a possibility to also make use of such data sets for a more refined understanding of the 3-D scanning properties. Building on some recent work on analysis of the distributional characteristics of iteratively reconstructed PET data, we construct an auto-regression model for analysis of the 3-D spatial auto-covariance structure of iteratively reconstructed data, after normalization. Appropriate likelihood-based statistical techniques for estimation of the auto-regression model coefficients are described. The fitted model leads to a simple process for approximate simulation of scanner performance-one that is readily implemented in an R script. The analysis provides a practical mechanism for evaluating the operational error characteristics of iteratively reconstructed PET images. Simulation studies are used for validation. The approach is illustrated on QA data from an operational clinical scanner and numerical phantom data. We also demonstrate the potential for use of these techniques, as a form of model-based bootstrapping, to provide assessments of measurement uncertainties in variables derived from clinical FDG-PET scans. This is illustrated using data from a clinical scan in a lung cancer patient, after a 3-minute acquisition has been re-binned into three consecutive 1-minute time-frames. An uncertainty measure for the tumor SUVmax value is obtained. The methodology is seen to be practical and could be a useful support for quantitative decision making based on PET data.


  • Open Access

    Combining Structural and Textural Assessments of Volumetric FDG-PET Uptake in NSCLC

    by Eric Wolsztynski, Janet O'SUllivan, Nicola M. Hughes, Tian Mou, Peter Murphy, Finbarr O'SUllivan, Kevin O'REgan

    Numerous studies have reported the prognostic utility of texture analyses and the effectiveness of radiomics in PET and PET/CT assessment of nonsmall cell lung cancer (NSCLC). Here we explore the potential, relative to this methodology, of an alternative model-based approach to tumour characterization, which was successfully applied to sarcoma in previous works. The spatial distribution of 3-D FDG-PET uptake is evaluated in the spatial referential determined by the best-fitting ellipsoidal pattern, which provides a univariate uptake profile function of the radial position of intratumoral voxels. A group of structural features is extracted from this fit that include two heterogeneity variables and statistical summaries of local metabolic gradients. We demonstrate that these variables capture aspects of tumour metabolism that are separate to those described by conventional texture features. Prognostic model selection is performed in terms of a number of classifiers, including stepwise selection of logistic models, LASSO, random forests and neural networks with respect to two-year survival status. Our results for a cohort of 93 NSCLC patients show that structural variables have significant prognostic potential, and that they may be used in conjunction with texture features in a traditional radiomics sense, toward improved baseline multivariate models of patient overall survival. The statistical significance of these models also demonstrates the relevance of these machine learning classifiers for prognostic variable selection.


  • The Gamma Characteristic of Reconstructed PET Images: Implications for ROI Analysis

    by Tian Mou, Jian Huang, Finbarr O'SUllivan

    The basic emission process associated with PET imaging is Poisson in nature. Reconstructed images inherit some aspects of this—regional variability is typically proportional to the regional mean. Iterative reconstruction using expectationmaximization (EM), widely used in clinical imaging now, impose positivity constraints that impact noise properties. The present work is motivated by analysis of data from a physical phantom study of a PET/CT scanner in routine clinical use. Both traditional filtered back-projection (FBP) and EM reconstructions of the images are considered. FBP images are quite Gaussian but the EM reconstructions exhibit Gamma-like skewness. The Gamma structure has implications for how reconstructed PET images might be processed statistically. Post-reconstruction inference— model fitting and diagnostics for regions of interest are of particular interest. Although the relevant Gamma parameterization is not within the framework of generalized linear models (GLM), iteratively re-weighted least squares (IRLS) techniques, which are often used to find the maximum likelihood estimates of a GLM, can be adapted for analysis in this setting. Our work highlights the use of a Gamma-based probability transform in producing normalized residuals as model diagnostics. The approach is demonstrated for quality assurance analyses associated with physical phantom studies—recovering estimates of local bias and variance characteristics in an operational scanner. Numerical simulations show that when the Gamma assumption is reasonable, gains in efficiency are obtained. The work shows that the adaptation of standard analysis methods to accommodate the Gamma structure is straightforward and beneficial.


  • Serial FDG-PET to predict response, time to skeletal related events, and survival in patients with bone-dominant metastatic breast cancer.

    by Jennifer M. Specht, Lanell Peterson, Alena Novakova, Janet N O'Sullivan, Finbarr O'Sullivan, Andrew Shields, Susan Montgomery, Hannah M. Linden, Julie Gralow, Georgiana Kehr Ellis, et al.

    11569 Background: Response to therapy in bone lesions can be difficult to assess. In this prospective study, FDG-PET was used to assess TTP, SRE and survival (OS) in patients (pts) starting a new therapy for bone-dominant metastatic breast cancer. Methods: Pts underwent an FDG-PET prior to starting new therapy and again at approximately 4 months. FDG static images were analyzed quantitatively using the maximum standardized uptake value (SUVmax) of up to 5 most dominant lesions. Response was determined by clinical follow-up data exclusive of PET results. Results: 29 pts (mean age 55, range 33-91) completed both FDG scans. At 35.5 mos median follow-up, 26/29 patients died from their disease (90%). Median OS was 32.7 mos (range 6-87). 27/29 (93%) pts had disease progression; median TTP was 5.7 mos (range 2.1-29.4); and 18/29 (62%) had an SRE; median time to SRE 6.5 mos (range 0-86.3). By univariate analysis, absolute change in the mean SUVmax between scans was not prognostic for TTP, SRE or OS. In multivariable analysis, after adjusting for presence of an elevated tumor marker and SUVmaxat baseline FDG-PET,a one standard deviation (2.6 units) reduction in SUVmax (averaged over tumor sites) at the second scan was associated with a 35% reduction in the risk of progression (p = .04). An increase of 5.9 SUV units was associated with a 70% increase in risk of progression. Absolute change in SUVmax from baseline, and initial higher SUVmax were associated with earlier time to SRE (p = .001, < .001, respectively). An increase of 5.9 SUV units over measured tumor sites was associated with more than a doubling of the risk of death (p = .01). The average difference between SUVmax at baseline and second scan was not significantly associated with OS (p = .13). Conclusions: Changes in SUVmax over the course of treatment in pts with bone-dominant breast cancer predicted TTP and SRE, but were of borderline significance in OS. High baseline SUVmax was associated with shorter time to SRE, shorter TTP and poorer OS. These results demonstrate a role for FDG-PET in assessing bone-dominant breast cancer response to therapy and support the use of FDG-PET as a response measure in future clinical trials. Support: 5R01CA124573-05


  • Open Access

    An Analysis of Whole Body Tracer Kinetics in Dynamic PET Studies With Application to Image-Based Blood Input Function Extraction

    by Jian Huang, Finbarr O'SUllivan

    In a positron emission tomography (PET) study, the local uptake of the tracer is dependent on vascular delivery and retention. For dynamic studies the measured uptake time-course information can be best interpreted when knowledge of the time-course of tracer in the blood is available. This is certainly true for the most established tracers such as 18F-Fluorodeoxyglucose (FDG) and 15O-Water (H 2O). Since direct sampling of blood as part of PET studies is increasingly impractical, there is ongoing interest in image-extraction of blood time-course information. But analysis of PET-measured blood pool signals is complicated because they will typically involve a combination of arterial, venous and tissue information. Thus, a careful appreciation of these components is needed to interpret the available data. To facilitate this process, we propose a novel Markov chain model for representation of the circulation of a tracer atom in the body. The model represents both arterial and venous time-course patterns. Under reasonable conditions equilibration of tracer activity in arterial and venous blood is achieved by the end of the PET study-consistent with empirical measurement. Statistical inference for Markov model parameters is a challenge. A penalized nonlinear least squares process, incorporating a generalized cross-validation score, is proposed. Random effects analysis is used to adaptively specify the structure of the penalty function based on historical samples of directly measured blood data. A collection of arterially sampled data from PET studies with FDG and H 2O is used to illustrate the methodology. These data analyses are highly supportive of the overall modeling approach. An adaptation of the model to the problem of extraction of arterial blood signals from imaging data is also developed and promising preliminary results for cerebral and thoracic imaging studies with FDG and H2O are obtained.


  • A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma

    by F. O'Sullivan, E. Wolsztynski, J. O'Sullivan, T. Richards, E. U. Conrad, J. F. Eary

    Clinical experience with positron emission tomography (PET) scanning of sarcoma, using fluorodeoxyglucose (FDG), has established spatial heterogeneity in the standardized uptake values within the tumor mass as a key prognostic indicator of patient survival. But it may be that a more detailed quantitation of the tumor FDG uptake pattern could provide additional insights into risk. The present work develops a statistical model for this purpose. The approach is based on a tubular representation of the tumor mass with a simplified radial analysis of uptake, transverse to the tubular axis. The technique provides novel ways of characterizing the overall profile of the tumor, including the introduction of an approach for the measurement of its phase of development. The phase measure can distinguish between early phase tumors, in which the uptake is highest at the core, and later stage masses, in which there can often be central voids in FDG uptake. Biologically, these voids arise from necrosis and fluid, fat or cartilage accumulations. The tumor profiling technique is implemented using open-source software tools and illustrations are provided with clinically representative scans. A series of FDG-PET studies from 185 patients is used to formally evaluate the prognostic benefit. Significant (p <; 0.05) improvements in the prediction of patient survival and progression are obtained from the tumor profiling analysis. After adjustment for other factors including heterogeneity, a typical one standard deviation increase in phase (as determined by the analysis) is associated with close to 20% more risk of progression or death. The work confirms that more detailed quantitative assessments of the spatial pattern of PET imaging data of tumor masses, beyond the maximum FDG uptake (SUVmax) and previously considered measures of heterogeneity, provide improved prognostic information for potential input to treatment decisions for future patients.